Supplier info centre > All product innovations
All products forSAFC PharmaSee also : Supplier info centre | All news headlines for SAFC Pharma |
 |
Product brochure
SAFC Pharma on Linking Biological Molecules to Highly Potent APIs - SAFC Pharma
16-Jun-2008 -
High-potent conjugated drugs are seen as a very promising emerging technology in cancer drug development. SAFC Pharma discusses what is needed to be an effective development partner in this complex area.
Product brochure
SAFC Pharma on Linking Biological Molecules to Highly Potent APIs - SAFC Pharma
24-Jun-2008 -
Medical researchers are arming themselves with a new series of weapons in the war against disease - conjugated drugs that link biological molecules to a highly potent active pharmaceutical ingredient (HPAPIs). Only a handful of companies have the combination of...
Technical / white paper
Multi-Purpose Microreactors - A Fast Track to Optimized Processes? - SAFC Pharma
11-Jun-2009 -
In this article SAFC Pharma looks at how the use of multi-purpose microreactors offers numerous benefits over traditional batch processors in the manufacture of certain chemical ingredients and intermediates. These benefits include continuous processing, improved heat transfer, precise temperature control,...
Product brochure
High-Potent Bioconjugation or Linking Biological Molecules to Highly Potent APIs - SAFC Pharma
28-Apr-2009 -
Medical researchers are arming themselves with a new series of weapons in the war against diseases – conjugated drugs that link biological molecules to a highly potent active pharmaceutical ingredient (HPAPIs). Cynthia Wooge, SAFC® process development manager and a...
Technical / white paper
Production of Pharmaceutical Compounds through Microbial Fermentation - SAFC Pharma
24-Jun-2009 -
In this article SAFC Pharma looks at the evolution of microbial fermentation and its applications in today’s pharmaceutical industry. The article also examines the advantages of fermentation technology in terms of economy, efficiency, timescale and yield over synthetic routes...
Technical / white paper
Handling Protocols Key Consideration in HPAPI Market - SAFC Pharma
18-Sep-2009 -
Over the past 10 years, the manufacture of highly potent active pharmaceutical ingredients (HPAPIs) has become increasingly attractive to contract manufacturers due to significant advances in clinical pharmacology and oncology research. In addition, with factors such as fewer FDA drug...
Technical / white paper
An Introduction to High-Potent API Classification - SAFC Pharma
12-Nov-2009 -
When dealing with highly potent compounds, it’s critical that failsafe procedures are in place relating to their handling, storage and containment. In order to ensure that the correct procedures are installed and adhered to, a logical system of classifying the...
Technical / white paper
Trends in the Manufacturing of Viral Gene Therapeutics and Next Generation Vaccines - SAFC Pharma
20-Jan-2010 -
The growing interest in gene therapy drugs and a resurgence in interest in vaccines have led to an increasing demand for large scale virus manufacture. Specialist contract manufacturers are able to make viruses quickly, safely and flexibly to meet this...
Technical / white paper
Cocrystal Engineering - A Promising Solution for Poor API Solubility - SAFC Pharma
04-Feb-2010 -
In order to turn an API into a successful pharmaceutical product, having a suitable crystal form of the molecule available is critical. This can often present significant hurdles that must be overcome. Here SAFC looks at how cocrystallization offers potential...
Case study
Fermentation Technology: Cooking Up New Therapeutics - SAFC Pharma
14-Apr-2010 -
Fermentation technology offers the pharmaceutical industry a reliable, powerful and economic source for chemical and biological therapeutic drugs.
Silvian Shama, Business Development Manager at SAFC’s new $29 million cGMP fermentation facility in Jerusalem, Israel, demonstrates the growing diversity of applications...
Case study
Characterization of hydrolysates to enhance CHO cell culture process understanding - SAFC Pharma
06-Jul-2010 -
Undefined components, such as protein hydrolysates, are routinely used in biopharmaceutical production to boost the growth and productivity of cells in culture. Due to regulatory concerns and variability associated with these components, a need for chemically defined basal formulations has...
Case study
SAFC's Approach to Productivity and Regulatory Compliance Improvements for Vaccine - SAFC Pharma
01-Dec-2010 -
This case study highlights the collaboration between SAFC and Oncolytics Biotech Inc, a Calgary, Canada-based biotechnology company, to address concerns of their novel cancer treatment, REOLYSIN®, and to assist in the development of a scalable and controlled production process.
